No. 10: MAKO Surgical
Q4 Return: -27%
Total Return: -49%
Investor: David Gardner
It wasn’t a pretty year for little-known MAKO Surgical (NASDAQ:MAKO), David Gardner’s high-risk selection for the best stock of 2012.
The company actually sat atop this list after the first quarter, then dropped nearly 40% in Q2 to sixth place. In Q3, the stock crumbled all the way to last place and kept slipping in Q4 — the tune of 27% losses — to finish there.
Several disappointing quarters — featuring wide losses and lowered outlooks — were to blame for the stock’s ugly performance. At the end of the year, the shares had lost an eye-popping 49%
Of course, MAKO was a volatile play to begin with. This small-cap, niche medical company was betting on a narrow product line — MAKOplasty procedures for knee and hip replacement surgeries — and that bet sure didn’t pay off in 2012.
Comments are currently unavailable. Please check back soon.